retatrutide phase 2 obesity trial results of a new medication, Retatrutide, showed the highest amount of weight loss in a clinical so far. 24% of body weight lost. An average of 58 pounds over 48 weeks! The medical management of Phase 2 trial results demonstrate

*clinical T stage, clinical N stage only available for n = 11 patients

As patients approach therapeutic doses over several weeks, appetite suppression becomes more consistent, cravings diminish further, and meal structure improves

I love this stuff it has given me back my willpower over food Have lost 6 lbs in 3 weeks and stopped disordered binge eating

Poeran J, Iban YC, Zhong H, Illescas A, Cozowicz C, Reisinger L, et al

Slowing ageing by design: The rise of NAD(+) and sirtuin-activating compounds

Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (step 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial